Birmingham, West Midlands -- (SBWIRE) -- 01/28/2014 -- Value Penny Stocks issues special report on Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Amarin Corporation plc (ADR) (NASDAQ:AMRN), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), JDS Uniphase Corp (NASDAQ:JDSU).
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) ended its recent business day with the loss of -4.36% and closed at the price of $4.39 after opening at $4.64. The stock traded during its last trading session with the total volume of 3,850,153 million shares, as compared to its average volume of 5.77 million shares. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products.
Has CHTP Found The Bottom and Ready To Move Up? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) remained among the day decliners and traded with volume of 3,750,477 shares in the last session, as compared to average volume of 7.87 million shares. In comparison with 52 week range of $1.36 - $8.98, it faced lowest price of $1.69 during the last trading session whereas its day highest price was $1.76. The company’s total market capitalization is $293.49 million, along with 172.64 million shares outstanding. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids.
Has AMRN Found The Bottom And Ready To Gain Momentum? Find Out Here
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) showed 3,682,114 shares in volume during the last trading session, while the average trading volume remained 1.37 million shares. The stock kicked off its trading session at $10.75 and closed at $9.81 after declining -15.43%. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop small molecule pharmaceuticals through the structure-guided drug design process.
Why Should Investors Buy BCRX After the Recent Fall? Just Go Here and Find Out
JDS Uniphase Corp (NASDAQ:JDSU) stock traded during its last trading session with the total traded volume of 3,547,457 shares versus its average volume of 5.56 million shares. The company opened its trade at the price of $11.80 and its closing price was $11.94 after gaining 1.36% for the day. JDS Uniphase Corporation provides communications test and measurement solutions, and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers, original equipment manufacturers, enterprises, government organizations, distributors, and strategic partners worldwide.
Why Should Investors Buy JDSU After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)